Last reviewed · How we verify

NCT07129005

Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids

ENROLLING BY INVITATION Last updated 19 August 2025
What this trial tests

trial testing No intervention (observational study) in Uterine Fibroid in 520 participants. Enrolling by invitation.

Timeline
1 January 2025
Primary endpoint
30 July 2025
30 December 2025

Quick facts

Lead sponsorTongji Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment520
Start date1 January 2025
Primary completion30 July 2025
Estimated completion30 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Tongji Hospital

Who can join

18 and older, female only, with Uterine Fibroid or Uterine Sarcoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective case-control study aims to develop and validate a diagnostic model based on multimodal big data and artificial intelligence to differentiate uterine leiomyoma from uterine sarcoma. Investigators will extract historical case data from existing inpatient and outpatient records, including medical history, physical and gynecological examination findings, MRI imaging data, laboratory results, and pathological records. The study seeks to address the question of whether integrating diverse retrospective clinical data with advanced AI techniques can accurately classify uterine tumors as benign leiomyomas or malignant sarcomas, thereby supporting clinical decision-making and optimizing diagnostic workflows.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention (observational study)

Trials testing the same drug.

Other recruiting trials for Uterine Fibroid

Currently open trials in the same condition.

Other Tongji Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07129005.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing